Soluble urokinase-type plasminogen activator receptor as a measure of treatment response in acute exacerbation of COPD.

Gehan Hassan AboEl-Magd Maaly Mohamed Mabrouk

Published in: Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia (2019)

Monitoring the serum suPAR level can be helpful in the evaluation of the COPD treatment response and might be a valuable biomarker for determining the prognosis of AECOPD. Because serum suPAR correlated with plasma fibrinogen, both markers could be predictive of AECOPD.

Keyphrases

chronic obstructive pulmonary disease
lung function
respiratory failure
liver failure
drug induced
cystic fibrosis
aortic dissection
hepatitis b virus